NEW UPDATE ALERT.....................
Lamotrigine is an antiepileptic medication used to treat epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration (FDA) issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.
McGraw-Hill INTERNAL UPDATES FORM
| Date: |
April 29, 2018 |
| Site: |
accesspharmacy.com |
| Title of Book and Edition: |
Pharmacotherapy: A Pathophysiologic Approach, 10th Edition |
| Author: |
DiPiro JT, et al, eds. |
| Chapter number/chapter title: |
Chapter 56: Epilepsy |
| Location of Update in the chapter: |
Treatment, Pharmacologic Therapy |
Content Update
April 29, 2018
Risk of Hemophagocytic Lymphohistiocytosis with Lamotrigine Use: Lamotrigine is an antiepileptic medication used for management of epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.
No comments yet.